BMC Pulmonary Medicine | |
Anti-synthetase syndrome-associated interstitial lung disease possibly caused by atezolizumab in a patient with lung adenocarcinoma: a case report | |
Case Report | |
Ryo Kusahana1  Yasuhiro Gon1  Yoshiko Nakagawa1  Ippei Miyamoto1  Daishi Fujiwara1  Tetsuo Shimizu1  Masayuki Nomoto1  Tsukasa Nishizawa1  Kentaro Hayashi1  | |
[1] Department of Respiratory Medicine, Nihon University Itabashi Hospital, Nihon University School of Medicine, 30-1, Oyaguchi-Kamicho, Itabashi-Ku, 173-8610, Tokyo, Japan; | |
关键词: Aminoacyl-tRNA synthetase (ARS); Anti-synthetase syndrome (ASS); Interstitial lung disease; Lung cancer; Immune checkpoint inhibitors (ICIs); | |
DOI : 10.1186/s12890-023-02446-z | |
received in 2022-11-01, accepted in 2023-04-13, 发布年份 2023 | |
来源: Springer | |
【 摘 要 】
BackgroundAnti-aminoacyl-tRNA synthetase (ARS) antibody-positive patients present with a variety of symptoms, including interstitial lung disease (ILD), which is termed anti-synthetase syndrome (ASS). But it is rare that ASS-ILD is considered an immune-related adverse event after the use of immune checkpoint inhibitors (ICIs).Case presentationA 47-year-old male with advanced lung adenocarcinoma was treated with platinum and ICI combination immunotherapy and was followed up as an outpatient. Nine months after the start of treatment, he developed a fever and cough, and imaging findings showed lung consolidations in the bilateral lower lung fields. The patient was positive for anti- ARS antibodies and was considered to have developed ASS-ILD due to ICIs remitted with steroid therapy. The patient was found to be positive for anti-ARS antibodies before ICI administration, and the antibody titer was elevated compared to that before ICI administration.ConclusionsThe examination of anti-ARS antibodies pior to the administration of ICIs may be useful in predicting the development of ASS-ILD.
【 授权许可】
CC BY
© The Author(s) 2023
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202308153347817ZK.pdf | 1791KB | download | |
41116_2023_36_Article_IEq327.gif | 1KB | Image | download |
41116_2023_36_Article_IEq350.gif | 1KB | Image | download |
41116_2023_36_Article_IEq353.gif | 1KB | Image | download |
MediaObjects/12888_2023_4767_MOESM1_ESM.pdf | 1353KB | download |
【 图 表 】
41116_2023_36_Article_IEq353.gif
41116_2023_36_Article_IEq350.gif
41116_2023_36_Article_IEq327.gif
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]